KOZARICH JOHN W sold 1.0% of their position (467.00 shares) of LIGAND PHARMACEUTICALS INC on the open market
Open‑market sale worth $89.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 11/5/2025ACC: 0002001011-25-000096
-467.00
Net shares
Net seller
$89.2K
Total sold
4
Open market trades
0B · 4S
4
Total transactions
467.00 disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
−84.00
Price / share
$189.00
Trade value
$15.88K
% of position
0.2%
11/3/2025
45.05K→44.97K
Common Stock
Direct
Shares
−49.00
Price / share
$190.26
Trade value
$9.32K
% of position
0.1%
11/3/2025
44.97K→44.92K
Common Stock
Direct
Shares
−207.00
Price / share
$191.25
Trade value
$39.59K
% of position
0.5%
11/3/2025
44.92K→44.72K
Common Stock
Direct
Shares
−127.00
Price / share
$192.38
Trade value
$24.43K
% of position
0.3%
11/3/2025
44.72K→44.59K
Total
Net shares
−467.00
Net value
-$89.22K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/3/2025 | S · Sale | −84.00 | $189.00 | $15.88K | 0.2% | 45.05K | 44.97K |
| Common Stock Direct | 11/3/2025 | S · Sale | −49.00 | $190.26 | $9.32K | 0.1% | 44.97K | 44.92K |
| Common Stock Direct | 11/3/2025 | S · Sale | −207.00 | $191.25 | $39.59K | 0.5% | 44.92K | 44.72K |
| Common Stock Direct | 11/3/2025 | S · Sale | −127.00 | $192.38 | $24.43K | 0.3% | 44.72K | 44.59K |
| Total | −467.00 | -$89.22K | ||||||
Derivative Transactions0
No derivative transactions reported